BBIO

BridgeBio Pharma, Inc.

Contracts

Total Value

Stock Metrics

15.3%

Short % Float

11.5d to cover · Moderate squeeze

98.3%

Inst % Float

10 holders · 2026-06-30

Kohlberg Kravis Ro

Top Holder

6.8% of float

152.7M sh

Public Float

-6.3% chg

25/100

Dilution Score

Low

14 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

25/100

LOW

Inst: 98.32% · Top: Kohlberg Kravis Roberts & Co. L.P.

Biotech Analytics

Oncology

10.69

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk25

Clinical Trials0

Short Interest50